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Introduction
Multi-drug resistant (MDR) Enterobacteriaceae are on
the increase worldwide and their spread has become a
global challenge. Escalating the challenge is the possibi-
lity that many of these are Carbapenemase-producing
Enterobacteriaceae (CPE). This further complicates
patient management. The magnitude of MDR-CPE in
many developed settings has been reported, however,
there is paucity of data from resource limited settings.
Objectives
We evaluated the epidemiology of MDR-CPE of clinical
origin in South Western Uganda.
Methods
From September 2013 to June 2014, all Enterobacteria-
ceae isolated from diverse specimens obtained from
patients attending Mbarara Regional Referral Hospital,
South-western Uganda, were screened for MDR in a
laboratory-based cross sectional study. Isolates found to
be MDR were screened for carbapenem susceptibility/
resistance phenotypically by Kirby Bauer disc diffusion
method following EUCAST guidelines and genetically
using the multiplex real-time Polymerase Chain Reaction
(RT-PCR).
Results
Of the 658 strains isolated, 183 (27.8%) were MDR and
68 (37.15%) of those MDR exhibited at least one form of
carbapenem resistance with 23 (12.57%) and 56 (30.60%)
isolates expressing phenotypic and genetic resistance,
respectively. Eleven MDR-CPE (6.01%) isolates exhibited
both phenotypic and genotypic resistance to carbape-
nems. Only blaVIM and blaOXA-48 genes were detected
among the genetically resistant isolates.
Conclusion
The high prevalence of MDR-CPE calls for aggressive
infection control and prevention strategies, including
reinforcement of hand hygiene, using contact precautions
and early detection of CPE through use of targeted sur-
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